688062.SH
迈威生物-U
SSE · Healthcare · Biotechnology · CN
CNY 29.23
−6.22%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 71.20x
Trailing multiples
Trailing twelve months
- P/E TTM
- -13.47x
- PEG TTM
- —
- Price / book
- 122.25x
- Price / sales
- 16.43x
- Price / cash flow
- -39.80x
Enterprise value
- Enterprise value
- CNY 13.4B
- EV / sales
- 17.92x
- EV / EBITDA
- -17.40x
- EV / EBIT
- -14.79x
- Market cap
- CNY 13.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026